lovastatin has been researched along with Mesothelioma in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, Y; Fukamachi, T; Kobayashi, H; Saito, H; Tagawa, M; Wang, X | 1 |
| Asakura, K; Fukutomi, T; Izumi, Y; Kawai, K; Nomori, H; Serizawa, A; Suematsu, M; Wakui, M; Yamauchi, Y | 1 |
| Adachi, T; Asakura, K; Izumi, Y; Kawai, K; Kawamura, M; Mizushima, T; Nakamura, M; Nomori, H; Ohmura, M; Serizawa, A; Suematsu, M; Wakui, M; Yamamoto, M; Yamauchi, Y | 1 |
| Betta, PG; Bosia, A; Ghigo, D; Orecchia, S; Pescarmona, G; Riganti, C | 1 |
| Aldieri, E; Betta, PG; Bosia, A; Gazzano, E; Ghigo, D; Orecchia, S; Pescarmona, G; Riganti, C; Silvagno, F | 1 |
| Bitterman, P; Greatens, T; Kratzke, RA; Polunovsky, VA; Rubins, JB; Tan, AT | 1 |
6 other study(ies) available for lovastatin and Mesothelioma
| Article | Year |
|---|---|
Tumor specific low pH environments enhance the cytotoxicity of lovastatin and cantharidin.
Topics: Cantharidin; Cell Growth Processes; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Inhibitors; HeLa Cells; Humans; Hydrogen-Ion Concentration; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mesothelioma; Pancreatic Neoplasms | 2010 |
Lovastatin and valproic acid additively attenuate cell invasion in ACC-MESO-1 cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autophagy; Cell Line, Tumor; Drug Synergism; Humans; Lovastatin; Mesothelioma; Neoplasm Invasiveness; Solitary Fibrous Tumor, Pleural; Valproic Acid | 2011 |
The cytostatic effects of lovastatin on ACC-MESO-1 cells.
Topics: Animals; Apoptosis; Autophagy; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cytostatic Agents; Disease Models, Animal; Humans; Inositol 1,4,5-Trisphosphate Receptors; Lovastatin; Male; Mesothelioma; Mice; Mice, Inbred NOD; Mice, SCID; Neuropeptides; Pleural Neoplasms; Prenylation; rac GTP-Binding Proteins; rac1 GTP-Binding Protein | 2011 |
Statins revert doxorubicin resistance via nitric oxide in malignant mesothelioma.
Topics: Amides; Antibiotics, Antineoplastic; Bacterial Proteins; Bacterial Toxins; Blotting, Western; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Electrophoretic Mobility Shift Assay; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mesothelioma; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Pyridines; Simvastatin | 2006 |
Asbestos induces nitric oxide synthesis in mesothelioma cells via Rho signaling inhibition.
Topics: Active Transport, Cell Nucleus; Amides; Animals; Asbestos, Crocidolite; Cattle; Cell Line, Tumor; Enzyme Activation; Enzyme Induction; Enzyme Inhibitors; Humans; I-kappa B Kinase; Isoenzymes; Lovastatin; Mesothelioma; Mevalonic Acid; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Proto-Oncogene Proteins c-akt; Pyridines; rho GTP-Binding Proteins; Second Messenger Systems; Terpenes | 2007 |
Lovastatin induces apoptosis in malignant mesothelioma cells.
Topics: Alkyl and Aryl Transferases; Antineoplastic Agents; Apoptosis; Cell Division; Cell Line; Cell Membrane; Cell Survival; Cytosol; DNA, Neoplasm; Dose-Response Relationship, Drug; Farnesol; Fibroblasts; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Mesothelioma; Mevalonic Acid; Protein Prenylation; ras Proteins; Tumor Cells, Cultured | 1998 |